IL6 and laryngotracheoesophageal cleft: Compared to age- and sex-matched controls, LC patients with mild–moderate COVID-19 had inflammatory mediator levels 8 months post-infection, including IL-6 and INF-γ, that were consistent with immunological dysfunction [118]..